ProfileGDS4177 / 211594_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 86% 88% 93% 91% 89% 90% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated346.8786
GSM603099KU-812 non-treated409.688
GSM603098KCL-22 Imatinib-treated735.993
GSM603097KCL-22 non-treated628.0691
GSM603102JURL-MK1 Imatinib-treated464.5789
GSM603101JURL-MK1 non-treated542.4490